India · Delayed Price · Currency is INR Medi-Caps Statistics
Total Valuation
Medi-Caps has a market cap or net worth of INR 314.12 million. The enterprise value is 74.98 million.
| Market Cap | 314.12M |
| Enterprise Value | 74.98M |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 12.47M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.08% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 61.75% |
| Owned by Institutions (%) | n/a |
| Float | 4.38M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.50 |
| PB Ratio | 0.28 |
| P/TBV Ratio | 0.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.60 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -11.47% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 13.94M |
| Profits Per Employee | -1.98M |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Medi-Caps has paid 141,000 in taxes.
| Income Tax | 141,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 47.10 |
| Average Volume (20 Days) | 38,870 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medi-Caps had revenue of INR 125.48 million and -17.79 million in losses. Loss per share was -1.43.
| Revenue | 125.48M |
| Gross Profit | 56.11M |
| Operating Income | -96.89M |
| Pretax Income | -17.64M |
| Net Income | -17.79M |
| EBITDA | -78.58M |
| EBIT | -96.89M |
| Loss Per Share | -1.43 |
Balance Sheet
The company has 239.14 million in cash and no debt, with a net cash position of 239.14 million.
| Cash & Cash Equivalents | 239.14M |
| Total Debt | n/a |
| Net Cash | 239.14M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.12B |
| Book Value Per Share | 89.53 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was -70.22 million and capital expenditures -8.46 million, giving a free cash flow of -78.69 million.
| Operating Cash Flow | -70.22M |
| Capital Expenditures | -8.46M |
| Depreciation & Amortization | 18.31M |
| Net Borrowing | n/a |
| Free Cash Flow | -78.69M |
| FCF Per Share | n/a |
Margins
Gross margin is 44.72%, with operating and profit margins of -77.22% and -14.17%.
| Gross Margin | 44.72% |
| Operating Margin | -77.22% |
| Pretax Margin | -14.06% |
| Profit Margin | -14.17% |
| EBITDA Margin | -62.63% |
| EBIT Margin | -77.22% |
| FCF Margin | n/a |
Dividends & Yields
Medi-Caps does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.08% |
| Shareholder Yield | -0.08% |
| Earnings Yield | -5.66% |
| FCF Yield | -25.05% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |